Kyverna Therapeutics
ID: 7390318Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Je***** Gr*** |
|
- | linkedin facebook |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ju*** Wi**** | - | - | - |
| Ry** Jo*** | - | - | - |
| Gr***** J. Gi**** | - | - | - |
| Do***** Bo*** |
|
- | |
| Ja*** Ch*** | - | - | linkedin facebook |
| To* Va* Bl***** | - | - |
Funding
Funding series
Funding Series Analysis
The company Kyverna Therapeutics has raised a total of $110m in funding over 2 rounds.
Key Insights:
- Kyverna Therapeutics Series B round, January 2022: $85m
- Kyverna Therapeutics Series A round, January 2020: $25m
Industries
Kyverna Therapeutics is active in the following industries: